<i>Mycobacterium abscessus</i>and Children with Cystic FibrosisIsabelle Sermet‐Gaudelus, Jean‐Louis Gaillard|Emerging infectious diseases|2003Cited by 159
Modulators of CFTR. Updates on clinical development and future directionsEmmanuelle Bardin, Isabelle Sermet‐Gaudelus, Alexandra Pastor et al.|European Journal of Medicinal Chemistry|2021Cited by 67
CFTR: New insights into structure and function and implications for modulation by small moleculesBertrand Kleizen, David N. Sheppard, J.F. Hunt et al.|Journal of Cystic Fibrosis|2019Cited by 20
Volatile metabolites differentiate air–liquid interface cultures after infection with <i>Staphylococcus aureus</i>Waqar Ahmed, Stephen J. Fowler, Emmanuelle Bardin et al.|The Analyst|2023Cited by 13
Lumacaftor/Ivacaftor Population Pharmacokinetics in Pediatric Patients with Cystic Fibrosis: A First Step Toward Personalized TherapyNaïm Bouazza, Isabelle Sermet‐Gaudelus, Emmanuelle Bardin et al.|Clinical Pharmacokinetics|2024Cited by 10